Chemotherapy options in castration-resistant prostate cancer

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Castration Resistant Prostate Cancer 100%
• Neoplasm 37%
• Biological Marker 37%
• Docetaxel 25%
• Prostate Cancer 12%
• Hormone Cancer Therapy 12%
• Combination Therapy 12%
• Prostate Specific Antigen 12%
• Immunotherapy 12%
• Androgen 12%
• Androgen Receptor 12%
• Taxane 12%
• Chemotherapy Agent 12%
• Cabazitaxel 12%

Keyphrases

• Novel Hormonal Therapy 14%
• Androgen Receptor Splice Variant 7 14%
• Agent Efficacy 14%
• Platinum Combinations 14%
• Tumor Cell Heterogeneity 14%
• Bone-targeted Therapy 14%

Medicine and Dentistry

• Cell Heterogeneity 16%
• Cabazitaxel 16%